KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Clover Health Investments (CLOV) Accumulated Depreciation & Amortization (2020 - 2024)

Clover Health Investments' Accumulated Depreciation & Amortization history spans 5 years, with the latest figure at $5.9 million for Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization rose 29.04% year-over-year to $5.9 million; the TTM value through Dec 2024 reached $5.9 million, up 29.04%, while the annual FY2024 figure was $5.9 million, 29.04% up from the prior year.
  • Accumulated Depreciation & Amortization reached $5.9 million in Q4 2024 per CLOV's latest filing, up from $4.6 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $5.9 million in Q4 2024 to a low of $1.8 million in Q4 2020.
  • Average Accumulated Depreciation & Amortization over 5 years is $3.4 million, with a median of $2.3 million recorded in 2021.
  • Peak YoY movement for Accumulated Depreciation & Amortization: dropped 0.04% in 2022, then soared 98.31% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $1.8 million in 2020, then grew by 25.93% to $2.3 million in 2021, then dropped by 0.04% to $2.3 million in 2022, then skyrocketed by 98.31% to $4.6 million in 2023, then grew by 29.04% to $5.9 million in 2024.
  • Per Business Quant, the three most recent readings for CLOV's Accumulated Depreciation & Amortization are $5.9 million (Q4 2024), $4.6 million (Q4 2023), and $2.3 million (Q4 2022).